Literature DB >> 9844038

Vaccination against meningococcus in complement-deficient individuals.

B P Morgan1, A Orren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9844038      PMCID： PMC1905138          DOI： 10.1046/j.1365-2249.1998.00734.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  26 in total

1.  How do mammals distinguish between pathogens and non-self?

Authors:  A Orren
Journal:  Trends Microbiol       Date:  1996-07       Impact factor: 17.079

2.  Efficacy of meningococcal vaccine and barriers to vaccination.

Authors:  N Rosenstein; O Levine; J P Taylor; D Evans; B D Plikaytis; J D Wenger; B A Perkins
Journal:  JAMA       Date:  1998-02-11       Impact factor: 56.272

3.  Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency.

Authors:  M Schlesinger; R Greenberg; J Levy; H Kayhty; R Levy
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

4.  Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine.

Authors:  A E Platonov; V B Beloborodov; L I Pavlova; I V Vershinina; H Käyhty
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

5.  Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.

Authors:  C A Fijen; E J Kuijper; M Drogari-Apiranthitou; Y Van Leeuwen; M R Daha; J Dankert
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

6.  Recurrent meningococcal septicaemia and properdin deficiency.

Authors:  N A Cunliffe; N Snowden; E M Dunbar; M R Haeney
Journal:  J Infect       Date:  1995-07       Impact factor: 6.072

7.  Antibody response to meningococcal polysaccharides A and C in patients with complement defects.

Authors:  R Biselli; I Casapollo; R D'Amelio; S Salvato; P M Matricardi; M Brai
Journal:  Scand J Immunol       Date:  1993-06       Impact factor: 3.487

8.  C3d of complement as a molecular adjuvant: bridging innate and acquired immunity.

Authors:  P W Dempsey; M E Allison; S Akkaraju; C C Goodnow; D T Fearon
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

9.  Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa.

Authors:  A Orren; D A Caugant; C A Fijen; J Dankert; E J van Schalkwyk; J T Poolman; G J Coetzee
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals.

Authors:  J Andreoni; H Käyhty; P Densen
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226
View more
  8 in total

Review 1.  Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.

Authors:  A Orren
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  Properdin deficiency and meningococcal disease--identifying those most at risk.

Authors:  S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 3.  Modern complement analysis.

Authors:  Michael Kirschfink; Tom E Mollnes
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

4.  Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.

Authors:  M Drogari-Apiranthitou; C A Fijen; D Van De Beek; E F Hensen; J Dankert; E J Kuijper
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

5.  A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.

Authors:  Kenneth T Mountzouros; Kelly A Belanger; Alan P Howell; Garvin S Bixler; Dace V Madore
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 6.  Antibody-mediated complement activation in pathology and protection.

Authors:  Benjamin S Goldberg; Margaret E Ackerman
Journal:  Immunol Cell Biol       Date:  2020-04-06       Impact factor: 5.126

7.  Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies.

Authors:  Peer Arts; Annet Simons; Mofareh S AlZahrani; Elanur Yilmaz; Eman AlIdrissi; Koen J van Aerde; Njood Alenezi; Hamza A AlGhamdi; Hadeel A AlJubab; Abdulrahman A Al-Hussaini; Fahad AlManjomi; Alaa B Alsaad; Badr Alsaleem; Abdulrahman A Andijani; Ali Asery; Walid Ballourah; Chantal P Bleeker-Rovers; Marcel van Deuren; Michiel van der Flier; Erica H Gerkes; Christian Gilissen; Murad K Habazi; Jayne Y Hehir-Kwa; Stefanie S Henriet; Esther P Hoppenreijs; Sarah Hortillosa; Chantal H Kerkhofs; Riikka Keski-Filppula; Stefan H Lelieveld; Khurram Lone; Marius A MacKenzie; Arjen R Mensenkamp; Jukka Moilanen; Marcel Nelen; Jaap Ten Oever; Judith Potjewijd; Pieter van Paassen; Janneke H M Schuurs-Hoeijmakers; Anna Simon; Tomasz Stokowy; Maartje van de Vorst; Maaike Vreeburg; Anja Wagner; Gijs T J van Well; Dimitra Zafeiropoulou; Evelien Zonneveld-Huijssoon; Joris A Veltman; Wendy A G van Zelst-Stams; Eissa A Faqeih; Frank L van de Veerdonk; Mihai G Netea; Alexander Hoischen
Journal:  Genome Med       Date:  2019-06-17       Impact factor: 11.117

8.  Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report.

Authors:  Ji Yun Bae; Ahrong Ham; Hee Jung Choi; Chung-Jong Kim
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.